Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
09/21/2000 | CA2364637A1 50 human secreted proteins |
09/21/2000 | CA2364635A1 47 human secreted proteins |
09/21/2000 | CA2364630A1 50 human secreted proteins |
09/21/2000 | CA2364629A1 Human lung cancer associated gene sequences and polypeptides |
09/21/2000 | CA2364590A1 Human prostate cancer associated gene sequences and polypeptides |
09/21/2000 | CA2364549A1 50 human secreted proteins |
09/21/2000 | CA2363022A1 49 human secreted proteins |
09/21/2000 | CA2363019A1 49 human secreted proteins |
09/21/2000 | CA2362897A1 Plant centromeres |
09/21/2000 | CA2361277A1 49 human secreted proteins |
09/20/2000 | EP1037158A2 Methods and apparatus for analyzing gene expression data |
09/20/2000 | EP1036188A1 ribG |
09/20/2000 | EP1036183A1 Mutations in atp-dependent transposition proteins that reduce target-site specificity |
09/20/2000 | EP1036178A1 Identification of lysolipid receptors involved in inflammatory response |
09/20/2000 | EP1036175A1 Human brain derived kcnq2 potassium channel |
09/20/2000 | EP1036171A2 Molecules interacting with apoptin |
09/20/2000 | EP1036168A1 Purification and microsequencing of hyaluronidase isozymes |
09/20/2000 | EP1036164A1 Chemokine alpha-5 |
09/20/2000 | EP1036162A1 Engraftable neural progenitor and stem cells for brain tumor therapy |
09/20/2000 | EP1036160A1 Strain of bacteria of the species lactobacillus paracasei subsp. paracasei, composition thereof for use in food and product containing said strain |
09/20/2000 | EP1036087A1 Secreted proteins and polynucleotides encoding them |
09/20/2000 | EP1036086A1 Caspase-14 polypeptides |
09/20/2000 | EP1035861A1 Threonine-containing protegrins |
09/20/2000 | EP1035856A1 Isolated dna encoding human h3 histamine receptor |
09/20/2000 | EP1035776A1 Fungi of the genus piriformospora |
09/20/2000 | EP0775211B1 Fumonisin detoxification enzymes |
09/20/2000 | EP0742834B1 Method of preparing a viral vector of at least 20kb by intermolecular recombination in a procaryotic cell |
09/20/2000 | EP0672057B1 Analogs of pth |
09/20/2000 | EP0600865B1 Xylanase production |
09/20/2000 | EP0586549B1 Selecting ligand agonists and antagonists |
09/20/2000 | CN1267307A Interleukin-18 binding proteins, their preparation and use |
09/20/2000 | CN1266905A Method for producing L-amino acid by fermentation with corynebacteria |
09/20/2000 | CN1266897A Process for fermenting lucid ganoderma in 18-ton fermentor |
09/20/2000 | CN1266889A Method for brewing health-care beer by secodary fermentation |
09/20/2000 | CN1266714A Humanized antibody |
09/20/2000 | CN1056649C 枯草杆菌蛋白酶变异体 Subtilisin variant |
09/20/2000 | CN1056646C Microbe and its application |
09/20/2000 | CN1056618C Acylated insulin and pharmaceutical composition contg. same |
09/20/2000 | CN1056617C Melanoma-inhibiting protein |
09/19/2000 | US6121521 Formed by joining the 5' portion of a synthetic maize optimized cry1b gene to the 3' end of a full-length synthetic maize optimized cry1a gene to generate a full-length hybrid cry1b gene |
09/19/2000 | US6121427 Major outer membrane protein CD of branhamella |
09/19/2000 | US6121426 Fibrin binding domain polypeptides and uses and methods of producing same |
09/19/2000 | US6121414 Protein which can be used to screen for antibiotic activity; for prevention of bacterial infections; bactericides |
09/19/2000 | US6121041 Use of microorganisms for decellularizing bioprosthetic tissue |
09/19/2000 | US6121038 Fabricating cell of microorganism capable of degrading hydrocarbons, encapsulating into pod which is activated in non-hydrocarbon environments, introducing pod into closed vessel of petroleum; if vessel is opened, cell becomes active |
09/19/2000 | US6121037 Nucleic acid which encodes protein having defined amino acid sequence; for diagnostic reagents against neisseria species infections such as gonorrhea and meningitis; vaccines |
09/19/2000 | US6121030 CSAPK-2 protein and uses therefor |
09/19/2000 | US6121029 Nucleotide sequences encoding at least one polypeptide from polyketide synthase; for recombinant production of anticarcinogenic agents |
09/19/2000 | US6121028 MurE |
09/19/2000 | US6121019 Polynucleotide fragment encoding human polypeptide of defined amino acid sequence; diagnosis, prevention, and treatment of inflammation, disorders associated with cell proliferation and apoptosis; antiinflammatory/antiproliferative agents |
09/19/2000 | US6121018 Polynucleotide which codes for polypeptide of defined amino acid sequence; for therapy and diagnosis of alzheimer's/ parkinson's diseases, multiple sclerosis, amyotrophic lateral sclerosis, septic shock, osteoporosis and other diseases |
09/19/2000 | US6120995 Compositions that specifically bind to colorectal cancer cells and methods of using the same |
09/19/2000 | US6120985 Pressure-enhanced extraction and purification |
09/19/2000 | US6120775 Administering a vaccine containing attenuated bacterium |
09/19/2000 | US6120774 Heterophil-adapted poultry vaccine |
09/19/2000 | US6120771 Isolated polypeptide; diagnosis, therapy |
09/19/2000 | US6120767 Genetic engineering |
09/19/2000 | CA2301407A1 Production of l-amino acids by fermentation using coryneform bacteria |
09/19/2000 | CA2273834A1 Immunomodulator, immunomodulator food and immunomodulator feed |
09/19/2000 | CA2166856C Water purification process and its apparatus |
09/19/2000 | CA2066378C Dehalogenation of organohalogen-containing compounds |
09/15/2000 | CA2300639A1 Methods and apparatus for analyzing gene expression data |
09/14/2000 | WO2000053807A1 Solid medium and process for the storage and rapid purification of nucleic acid |
09/14/2000 | WO2000053801A1 Intact cell assay for protein tyrosine phosphatases |
09/14/2000 | WO2000053792A1 Substances wk-5344a and wk-5344b and process for producing the same |
09/14/2000 | WO2000053781A1 Generation of conditional yeast mutants, methods and reagents related thereto |
09/14/2000 | WO2000053778A1 Promoters |
09/14/2000 | WO2000053777A1 Preparation of peptides by use of human glucagon sequence as a fusion expression partner |
09/14/2000 | WO2000053772A1 Dna polymerase from pyrobaculum islandicum |
09/14/2000 | WO2000053769A1 Novel thioredoxin family active site molecules and uses therefor |
09/14/2000 | WO2000053756A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
09/14/2000 | WO2000053750A1 Compositions and methods for the treatment of tumors |
09/14/2000 | WO2000053748A2 Casb618 polynucleotides and polypeptides and their use |
09/14/2000 | WO2000053742A2 Polynucleotides and proteins encoded thereby |
09/14/2000 | WO2000053737A2 Mitomycin biosynthetic gene cluster |
09/14/2000 | WO2000053733A2 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
09/14/2000 | WO2000053726A1 Process for producing l-lysine |
09/14/2000 | WO2000053725A1 Expression of proteolytic enzymes in koji mold in the presence of carbon sources |
09/14/2000 | WO2000053723A2 Scarecrow gene, promoter and uses thereof |
09/14/2000 | WO2000053634A1 Single-stranded fv inducing apoptosis |
09/14/2000 | WO2000053633A2 Antibody and chemokine constructs that are directed to ccr5, and their use for treating autoimmune diseases |
09/14/2000 | WO2000053631A1 Mammalian cytokines; related reagents and methods |
09/14/2000 | WO2000053628A2 Genes encoding human potassium channel proteins |
09/14/2000 | WO2000053304A1 A vessel for mixing a cell lysate |
09/14/2000 | WO2000053232A1 Matriptase, a serine protease and its applications |
09/14/2000 | WO2000053202A1 Lactobacillus strains capable of preventing diarrhoea caused by pathogenic bacteria and rotaviruses |
09/14/2000 | WO2000053201A1 Lactic acid bacteria strains capable of preventing diarrhoea |
09/14/2000 | WO2000053200A1 Lactobacillus strains preventing diarrhoea pathogenic bacteria |
09/14/2000 | WO2000043504B1 PROTEIN ENGINEERING OF GLUCOAMYLASE TO INCREASE pH OPTIMUM, SUBSTRATE SPECIFICITY AND THERMOSTABILITY |
09/14/2000 | WO2000037685A3 Method of identifying a psychotropic agent using differential gene expression |
09/14/2000 | WO2000037609A3 Orally immunogenic bacterial enterotoxins expressed in transgenic plants |
09/14/2000 | WO2000037504A3 Human monoclonal antibodies to ctla-4 |
09/14/2000 | WO2000031263A3 Gtpase associated proteins |
09/14/2000 | WO2000031132A8 Novel polypeptide |
09/14/2000 | WO2000030425A3 Method of using pon-1 to decrease atheroma formation |
09/14/2000 | WO2000026408A3 A system for cell-based screening |
09/14/2000 | WO2000024893A3 Methods and compositions for the prevention and treatment of anemia |
09/14/2000 | WO2000024770A3 Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity |
09/14/2000 | WO2000023588B1 G-protein coupled receptors |
09/14/2000 | WO2000022129A9 Non-endogenous, constitutively activated human g protein-coupled receptors |